Dr. Sanjiv Dhingra, associate professor of physiology and pathophysiology, was granted Canadian Institutes of Health Research funding for $960,076 over five years. His work is looking at therapies using adult stem cells derived from young and healthy donors to help repair heart damage in older patients with a history of heart disease. Read more.
Dr. Pingzhao Hu, associate professor of biochemistry and medical genetics, has been awarded five-year funding ($210,000) by NSERC for his research project titled Flexible and robust deep learning models for integrative analysis of single-cell RNA sequencing data. He has been awarded one-year funding ($90,000) by Mitacs for his research project titled Deep Learning Models for Compound Design.
Dr. Alyson Mahar, assistant professor of community health sciences, and Dr. Tanveer Sharif, assistant professor of pathology, who were each awarded five-year Canadian Cancer Society Emerging Scholar awards for their projects Measuring Equity and Generating ActioN in CANcer: Using research to promote equitable care delivery across Canada (MEGAN CAN) and Effect of standard chemoradiotherapy interventions on metabolism and stemness in glioblastoma respectively.
Dr. Yvonne Myal, professor and associate head of pathology, and professor of physiology/pathophysiology and a senior investigator at the CancerCare Manitoba Research Institute, and Dr. Tanveer Sharif, assistant professor of pathology, were each awarded two-year operating grants from the Cancer Research Society in partnership with Canadian Institutes of Health Research. Dr. Myal’s project is The role of prolactin-inducible protein (PIP) in promoting breast cancer metastasis in the lung and Dr. Sharif’s project is Therapeutic exploitation of metabolic rewiring in tumour heterogeneity.
Dr. Mojgan Rastegar, professor of biochemistry and medical genetics, received the Ontario Rett Syndrome Association Award ($50,000). Read more.
Dr. George Zhanel, professor of medical microbiology/infectious diseases and director of the Canadian Antimicrobial Resistance Alliance (CARA) is pleased to announce that CARA, which is headquartered in the Max Rady College of Medicine, has received grant funding to establish a new national registry called the Canadian Leadership on Antimicrobial Real Life Usage (CLEAR). CLEAR is national antimicrobial usage registry that captures the clinical usage of new intravenous antimicrobials allowing clinicians across Canada to share their data about why, when and how they use these agents to treat patients with infectious diseases.
Extramural grants on which the department of emergency medicine faculty are co-Investigators, co-applicants or PIs:
- Dr. Malcom Doupe, primary investigator, and Dr. Alecs Chochinov, co-applicant – Research funding amount: $2,342,647 for From Knowledge to Action: Developing interventions to improve older adult care transitions between nursing homes and emergency wards
- Dr. Malcom Doupe, primary investigator, and Dr. Alecs Chochinov, team member – Research funding amount: $609,979 for iNET: An International Network to Enhance Older Transitions between Emergency Departments & Communities
- Dr. Murdoch Leeies, co-investigator – Research funding amount: $99,000 for Utilizing Operations Management to Minimize Emergency Department Wait Times and Improve Patient Flow
- Drs. Murdoch Leeies and Tomislav Jelic, co-applicants – Research funding amount: $499,945 for Investigating the Post-Acute Sequelae of SARS-CoV-2 Infections: a Patient Oriented Canadian COVID-19 Emergency Department Rapid Response Network (CCEDRRN) Study